Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	64.14	44.51	27.17	20.29	28.02	16.5
Cash & Short-Term Investments	64.14	44.51	27.17	20.29	28.02	16.5
Cash Growth	98.90%	63.80%	33.93%	-27.59%	69.84%	-11.36%
Accounts Receivable	8.51	7.77	5.23	8.48	5.23	2.69
Other Receivables	0.6	0.9	-	-	-	-
Receivables	9.11	8.67	5.23	8.48	5.23	2.69
Inventory	18.79	9.19	14.53	14.68	13.6	11.68
Prepaid Expenses	1.43	1.58	2.45	2.97	1.86	1.15
Restricted Cash	0.15	0.15	0.15	0.15	0.2	0.2
Total Current Assets	93.62	64.1	49.53	46.57	48.91	32.22
Property, Plant & Equipment	3.86	3.45	4.54	6.32	7.36	4.43
Other Intangible Assets	0.25	0.36	0.51	0.67	0.86	1.08
Other Long-Term Assets	0.42	0.37	0.38	0.5	0.72	0.63
Total Assets	98.14	68.28	54.96	54.06	57.84	38.36
Accounts Payable	12.74	8.53	10.23	9.68	10.42	9.45
Accrued Expenses	8.7	7.82	9.49	7.34	6.48	6.13
Current Portion of Leases	0.98	0.99	0.7	0.7	0.55	0.62
Current Unearned Revenue	0.29	0.61	0.2	0.16	0.16	0.28
Total Current Liabilities	22.71	17.95	20.62	17.87	17.61	16.48
Long-Term Leases	2.08	1.66	2.58	3.56	4.15	1.02
Long-Term Unearned Revenue	2.67	2.58	3.31	3.96	4.35	4.44
Total Liabilities	27.46	22.18	26.51	25.39	26.11	21.93
Common Stock	0.08	0.08	0.08	0.07	0.07	0.06
Additional Paid-In Capital	239.27	227.93	218.85	214.09	200.61	158.19
Retained Earnings	-168.66	-181.91	-190.46	-185.49	-168.95	-141.83
Comprehensive Income & Other	-0.01	-0	-0	-0	-0	-0
Shareholders' Equity	70.68	46.09	28.46	28.67	31.73	16.42
Total Liabilities & Equity	98.14	68.28	54.96	54.06	57.84	38.36
Total Debt	3.06	2.65	3.28	4.26	4.7	1.64
Net Cash (Debt)	61.08	41.86	23.9	16.03	23.32	14.86
Net Cash Growth	108.11%	75.16%	49.05%	-31.24%	56.91%	-12.04%
Net Cash Per Share	0.72	0.54	0.32	0.23	0.35	0.24
Filing Date Shares Outstanding	80.09	77.92	75.48	75.02	68.49	66.92
Total Common Shares Outstanding	79.92	77.5	75.15	74.75	68.31	62.06
Working Capital	70.9	46.15	28.91	28.7	31.29	15.74
Book Value Per Share	0.88	0.59	0.38	0.38	0.46	0.26
Tangible Book Value	70.43	45.74	27.95	28	30.87	15.34
Tangible Book Value Per Share	0.88	0.59	0.37	0.37	0.45	0.25
Machinery	-	3.97	4.26	4.05	4.3	3.92
Construction In Progress	-	0.09	0.01	0.17	0.09	0
Leasehold Improvements	-	2.21	2.15	2.06	2.39	2.36

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q